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O topiramato, que é uma poderosa droga anticonvulsiva utilizada para controlar os sintomas da 
epilepsia, foi investigado pelas técnicas de difratometria de raios X, FT-Raman, FT-infravermelho, 
análise termogravimétrica, análise térmica diferencial e cálculos com teoria do funcional de 
densidade. A partir deste estudo foi possível identificar a maior parte das bandas observadas nos 
espectros Raman e infravermelho. Das análises térmicas, efetuadas da temperatura ambiente até 
900 oC, verificou-se que o material não apresenta nenhuma mudança de fase e que a decomposição 
ocorre num processo exotérmico de duas etapas.
Topiramate, a powerful anticonvulsant drug, was investigated by X-ray diffractometry,  
FT-Raman, FT-IR, TGA and DTA techniques as well as by DFT calculations. From this study it 
was possible to tentatively assign most of the normal vibrational modes of the crystal. Thermal 
analysis from room temperature to 900 oC shows that the material does not present any structural 
phase transition and that the decomposition occurs in a two-step exothermic process.
Keywords: organic crystals, vibrational spectra, X-ray diffraction, thermodynamic 
properties
Introduction
Epilepsy is a set of neurological disorders that range 
from brief cessation of responsiveness to severe muscle 
spasms with a loss of conciousness. In the last years some 
drugs have been tailored with the objective of controlling 
epileptic symptoms, the so called anticonvulsant drugs. 
Among these drugs, one of the most efficient and 
powerful as antiepileptic is topiramate,1 a crystalline white 






S and structural 
formula shown in Figure 1. Topiramate (2,3:4,5-bis-O-
methylethylidene-β-D-fructopyranose sulfamate) is derived 
from a monosaccharide by addition of a sulfamate group, 
and was discovered by Maryanoff et al.2 in 1987, exhibiting 
a remarkable anticonvulsant activity. Since the late 1990s 
it has been used to treat epilepsy (its trade names are 
Topamax®, Topimax® or Topamac®) and has recently also 
been used to prevent migraine headaches in adults.3
In the last years, many works have reported physical-
chemical characterization of drugs in order to determine 
several important aspects, such as the influence of 
processing and formulation of solid pharmaceuticals, 
polymorphisms, the relationship between physical 
structures and their properties, among others.4 Although 
many clinical properties of topiramate have already 
been investigated, very few papers address its structural 
and physical-chemical properties. One of these is from 
Figure 1. Structural formula of topiramate.
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Kubicki et al.,5 which presents a detailed description of its 
crystal structure obtained from X-ray diffraction data. The 







, with cell parameters a = 7.2497 Å, b = 11.0007 Å, 
c = 19.6291 Å, and Z = 4. Also, there are some works 
published on stability analysis of topiramate,6 especially 
on the development of techniques to detect sulfamate and 
sulfate ions resulting from topiramate decomposition. 
However, neither thermogravimetric analysis (TGA) nor 
differential thermal analysis (DTA) results were shown 
or discussed with regard to possible phase transitions or 
to further characterize thermal events. On the other hand, 
Fourier transform (FT)-Raman and FT-infrared (IR) 
spectroscopies have been used in the last years as alternative 
techniques to characterize drug molecules, to reveal the 
solid-state properties arising from polymorphism, and to 
identify active ingredients and excipients in a drug mixture, 
among others.7
The purpose of this paper is two-fold. First, to present 
the FT-Raman and FT-IR spectra of topiramate, providing 
a tentative assignment of the bands observed. Second, we 
shed light on the thermal behavior of topiramate crystal, in 
particular, reporting a two-step, exothermic decomposition 
process.
Experimental
Topiramate (HPLC 99.7%) was provided by Janssen-
Cilag Farmacêutica S.A. and used without further 
purification. In order to obtain the crystals, a saturated 
aqueous solution was prepared and left to stand at 293 K. 
Within a week, small, colorless crystals (up to 3 mm on 
the longest axis), parallelepiped shaped, were collected. 
X-ray powder diffraction data were collected on a Rigaku 
D/MAX 2400, using a θ - 2θ geometry, rotating anode source, 
Cu-Kα radiation (1.542 Å) and scintillation detector. Typical 
2θ angular scans ranging from 5 to 75o in varying steps of 
0.02o were used in these experiments.
All vibrational measurements were carried out at 
room temperature. FT-Raman spectra of topiramate were 
obtained with a Bruker RFS 100/S, using the 1064 nm line 
of a Nd:YAG laser as exciting source, with a power output 
of 150 mW. The spectral resolution was set to 4 cm-1, and 
the signal/noise ratio was enhanced by 60 scans in the range 
of 70 cm-1 to 4000 cm-1. FT-IR spectrum was obtained on 
a Bruker EQUINOX 55, using a spectral resolution of 
4 cm-1. The signal/noise ratio was enhanced by 60 scans 
from topiramate powder in KBr pellets in the range of 
3500 cm-1 to 400 cm-1. The vibrational frequencies of the 
topiramate molecule were calculated by Density Functional 
Theory (DFT) using the Gaussian98 package,8 with the 
B3LYP method and 6-31G(d,p) basis set, after a suitable 
geometry optimization. Calculated vibrational spectra 
(infrared and Raman) were plotted by fitting Lorentzian 
functions to the peaks, with 10 cm-1 FWHM (full width at 
half maximum). These were graphically (scale factor set 
to unity) compared to the experimental results and, with 
the aid of a visualization software, assisted the vibrational 
assignments.
Crystal samples were analyzed on a SDT Q600, from 
TA Instruments, performing TGA and DTA simultaneously. 
The first experimental condition employed was a heating 
rate of 10 °C min-1 under 100 mL min-1 nitrogen flux, 
from 22 to 990 °C. In order to understand the DTA curve 
around 180 °C in detail, a second condition was employed, 
with a heating rate of 2 °C min-1, also under 100 mL min-1 
nitrogen flux, from 19 to 350 °C. In both cases, samples 
were maintained in a platinum pan.
Results and Discussion
The X-ray powder diffraction pattern obtained from 
our samples is shown in Figure 2. Sample grinding may 
have led to some crystals becoming amorphous, which 
would explain the baseline deviation around 25°. In order 
to determine whether the sample had the same structure 
as previously reported in the literature, we calculated all 
the allowed diffraction angles in the range of 5 to 75° 
and matched to the observed peaks. Excellent agreement 
was obtained. The most intense peaks, together with their 
diffraction planes, are listed in Table 1.
Figure 3 presents the Raman spectrum of the powder 
sample of topiramate crystal in the range 70-3500 cm-1 and 
Figure 2. X-ray powder diffraction pattern of topiramate (ground 
crystals). 
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Figure 4 presents the FT-IR spectrum of topiramate powder 
in KBr for the spectral region 400-3500 cm-1. Both spectra 
are shown with an axis break from 1650 to 2550 cm-1 due 
to absence of peaks and to improve clarity. Modes with 
wavenumber lower than 150 cm-1 are generally assigned as 
lattice modes.9 The tentative assignments of bands observed 
in the Raman and in the IR spectra of topiramate, based 
on published vibrational studies on other sulfamates10-17 
and studies on other correlated materials,18-23 as well as 
DFT calculations, are given in Table 2. In each case, the 
most intense band was given a value of 100, and relative 
intensities are shown in parentheses.
According to DFT calculations, the first peaks in this 
region are associated with C-C torsional motion from methyl 
groups, at 240, 269, and 278 cm-1, with a considerable 
contribution of N-S torsion in the first one. However, the 
N-S torsion is tentatively attributed to the band at 332 cm-1, 
closer to 300 cm-1 as assigned to other sulfamates,14,15,17 
and accounting for hydrogen bonding effects. The bands 
at 352 and 386 cm-1 are assigned, respectively, to the SO
3
 
group symmetric and asymmetric rocking modes, also 
as in other sulfamates. The angular deformations for this 
same group are seen at 506 and 554 cm-1 (symmetric), 
and 585 cm-1 (asymmetric). Angular deformations are also 
found at 641, 669 and 708 cm-1, involving O-C-O, C-O-C 
and C-C-O bending. Ring breathing modes are observed, 
according to DFT, at 756 cm-1 (6-membered-ring) and 
788 cm-1 (5-membered-ring).
In the optimized geometry, the N-S bond length 
(1.668 Å) is close to the one in potassium sulfamate 
(1.666 Å),12 but the stretching frequency was calculated at 
the higher value of 859 cm-1 (unscaled). In the crystal the 
bond length is 1.576 Å, so this mode was assigned to the band 
at 806 cm-1. The group of bands 825, 842, 864 and 881 cm-1 
are associated with ring deformations due to coupled 
skeletal stretching and bending modes. Methylene groups 
rocking modes are assigned separately, the exocyclic one at 
928 cm-1 and the endocyclic at a slightly higher frequency 
of 952 cm-1, due to steric effects from the ring. Rocking 
from CH
3
 groups is observed at 966 and 980 cm-1.
The weak band in the Raman spectrum at 1018 cm-1, 
with the same frequency but stronger in the infrared, is 
assigned to stretching of the C-O bond that holds the 
sulfamate group and agrees very well with the calculated 
value of 1022 cm-1 (unscaled).
Table 1. Predicted diffraction angles for crystalline topiramate, with the 
corresponding observed angles and planes of reflection
Calc. Expt. h k l
9.22 9.26 0 1 1
12.08 12.10 0 1 2
13.02 13.00 1 0 1
14.63 14.66 1 1 0
15.32 15.28 1 1 1
16.11 16.02 0 2 0
17.21 17.28 1 1 2
19.98 19.90 1 1 3
20.77 20.76 1 2 1
24.45 24.48 1 2 3
25.81 25.74 1 0 5
32.88 32.86 0 4 1
35.95 35.94 0 2 7
36.82 36.78 0 3 6
40.03 39.92 0 4 5
Figure 3. FT-Raman spectrum of topiramate powder, showing the range 
from 70-3500 cm-1, with a break between 1650 and 2550 cm-1.
Figure 4. FT-IR spectrum of topiramate powder (KBr pellet) showing the 
range from 400-3500 cm-1, with a break between 1650 and 2550 cm-1.
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102 (004) – lattice modes 1059 (005) 1059 (023) ν C-O (rings)
114 (004) – lattice modes – 1074 (100) ν C-O (rings)
134 (005) – lattice modes 1085 (010) – ν C-O (rings)
155 (007) – lattice modes 1097 (003) – ν C-O (rings)
169 (002) – lattice modes 1102 (009) 1102 (060) ν C-O (rings)
198 (003) – – 1116 (004) 1116 (034) tw NH
2




240 (018) – τ C-C 1176 (011) 1175 (034) ν CCC, CCO




278 (014) – τ C-C 1213 (005) 1211 (084) tw CH
2
, (+ d CH)
332 (007) – τ N-S 1226 (004) 1228 (026) tw CH
2
, (+ d CH)












1268 (006) 1263 (035) tw CH
2
, (+ d CH)
394 (002) – – 1281 (007) 1282 (024) tw CH
2
, (+ d CH)
434 (004) 431 (010) d CCC 1291 (003) 1293 (022) tw CH
2
, (+ d CH)
463 (001) – – 1315 (004) 1316 (017) d C-H in phase
      – 501 (019) – – 1325 (007) –




1340 (005) – d C-H out of phase
523 (002) 523 (030) – 1354 (001) 1357 (092) ω CH
2









1382 (003) – –































788 (026) 790 (089) breathing (5-ring) – 2666 (010) overtone
806 (011) 805 (009) ν N-S 2739 (006) 2736 (006) overtone
825 (001) 826 (036) ring modes 2888 (008) 2844 (001) overtone
842 (001) 839 (031) ring modes 2909 (045) 2910 (032) ν C-H
























 out of phase
928 (007) 928 (028) ρ CH
2





952 (006) 951 (056) ρ CH
2




966 (012) 965 (041) ρ CH
3




980 (005) 979 (023) ρ CH
3








1018 (002) 1018 (062) ν C-O (exo) – – –
ρ = rocking; τ = torsion; ω = wagging; d = bending; ν = stretching; as = asymmetric; s = symmetric; tw = twisting.
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As observed from other sulfamates, the SO
3
 group gives 
rise to three symmetric and one asymmetric stretching 
vibrations. This is due to a lifting of degeneracy by the 
crystal symmetry. One of each kind was observed in the 
calculations, the symmetric at 1164 cm-1 and the other at 
1390 cm-1, coupled to other vibrations. The former was 
assigned to the band at 1164 cm-1, together with 1045 and 
1186 cm-1, and the latter at 1259 cm-1, in better agreement 
with the literature. The calculated frequency of 1183 cm-1 
is attributed to CCC and CCO stretching, and tentatively 
assigned to the peak at 1176 cm-1.
The group of bands from 1059 to 1102 cm-1 are 
associated with C-O stretching from the rings, in agreement 
with DFT calculations, except for the peak at 1102 cm-1 
which is shown as a twist from the NH
2
 group. This mode 
is assigned to the band at 1116 cm-1 in order to account for 
hydrogen bonding effects, and to be closer to the literature 
values.
The next group, from 1213 to 1291 cm-1, except for 
the band at 1259 cm-1, comprises bands assigned to CH
2
 
twisting vibrations, usually coupled to bending of CH, 
with the modes involving the exocyclic methylene group 




Bending vibrations from CH groups are assigned 
to the bands in 1315 (in phase) and 1340 cm-1 (out of 
phase, Raman only). The very weak peak at 1354 cm-1 
in the Raman spectrum, but very intense in the infrared, 
is assigned to the CH
2
 wagging vibration. Methyl groups 
symmetric deformations (umbrella) are assigned to the 
bands at 1371 and 1391 cm-1.
Asymmetric bending from CH
3
 groups are assigned 
to bands at 1431 and 1438 cm-1, followed by symmetric 
bending (scissoring) from methylene groups, the exocyclic 
at 1455 cm-1 and the endocyclic at 1465 cm-1, as in 
fructopyranose.22 Last in the low frequency region is the 
NH
2
 scissoring mode at 1581 cm-1, one of the highest values 
as compared to other sulfamates.
The high-wavenumber range (higher than 2700 cm-1) 







 groups are expected to be observed. As occurs with 




 units, this region 
is the spectral range where the most intense peaks in the 
Raman spectra are observed.9 The stretching vibrations of 
NH
2 
are found with the highest energies: the asymmetric 
stretching is the peak at 3380 and 3385 cm-1, respectively, in 
the Raman and in the IR spectra. The symmetric stretching, 
on its turn, is observed as a doublet at 3243 and 3210 cm-1 
in the Raman spectrum, and at 3251 and 3206 cm-1 in 
the infrared. This is attributed to the fact that, within the 
crystal, topiramate molecules are held together in linear 
chains by asymmetric hydrogen bondings (only one of 
the hydrogens in the amine group participates), running 
in opposite directions. The peak observed at ca. 3110 cm-1 
can be attributed to an overtone due to Fermi resonance 
from the amine group scissoring mode, as occurs for other 
sulphamates.10,11,14 The asymmetric stretchings of CH
3
 are 
observed at 3003 (in phase) and 2989 cm-1 (out of phase), 
followed by the asymmetric stretching of endocyclic CH
2
 
group at 2979 cm-1. The band observed at 2962 cm-1 is 
assigned to the symmetric stretching of exocyclic CH
2
; 
this value is almost 30 cm-1 higher than that observed for 
fructopyranose.20 This is attributed to the presence of the 
sulfamate group, and supported by the DFT calculations. 
Additionally, DFT calculations indicate that the peaks at 
2933 and 2945 cm-1 are associated to symmetric stretching 
of CH
3
, while stretching of CH
 
is observed at 2909 cm-1.
The band at 2736 cm-1 could be seen as originated from 
an aldehyde group formed after a partial ring-opening, 
possibly caused by water in the sample. However, this band 
is also observed in Raman experiments performed on single 
crystals (not shown), where the effect of water is negligible, 
so a possible source for this mode is the overtone of the 
band at 1371 cm-1. Following the same reasoning, the bands 
2666 (infrared only) and 2888 cm-1 were also tentatively 
assigned as overtones.
We also performed a thermal analysis study in order 
to obtain information about both (i) possible polymorphic 
modification of the material and (ii) the decomposition 
process occurring at high temperatures. It is well known 
that to screen for polymorphs of a certain crystal we would 
have to perform crystallization experiments from a diverse 
range of solvents. Also, for a specific solvent it is possible 
to obtain crystals with different symmetries depending on 
parameters such as pH and temperature.23 However, for each 
polymorph, the temperatures of the phase transformations 
are well established and, as a consequence, the thermal 
analysis is an important tool to search for polymorphism. 
The discovery of new polymorphs is important because an 
understanding of the diverse solid state forms can lead to 
better design and control of drug performance. With these 
objectives we performed TGA and DTA measurements. 
In a first run of TGA, a mass loss of 46.8% was observed 
around 180 °C, followed by a further mass loss of 20.8% 
in the interval 180-270 °C. Then, mass continues to 
reduce slowly until the temperature reaches 990 °C, when 
only 17.8% of the total mass is present. DTA exhibited an 
endothermic peak at 127.1 °C due to melting of the sample, 
and another endothermic peak at 177.1 °C, immediately 
followed by a highly exothermic “loop” at 183.4 °C. This 
loop is due to a heat release greater than the heating rate 
of the instrument, which makes it stop heating and then 
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recovers after the process is finished. These results are 
shown in Figure 5.
In order to further shed light on the phenomenon in the 
region around 180 °C, a lower heating rate was employed. 
TGA results (not shown) were roughly the same (44.4% 
mass loss around 180 °C, followed by a 19.7% mass loss 
up to 260 °C), but DTA recorded melting at 121.4 °C and 
two sharp exothermic peaks (179.6 and 181.3 °C) instead 
of the loop just following the endothermic peak at 178.5 °C, 
as shown in Figure 6.
According to the literature, topiramate melts between 
125 and 126 °C.1 The deviations observed experimentally 
are due to the different heating rates used, the higher 
the rate, higher the melting temperature observed. The 
endothermic peak at 178 °C is attributed to the first 
stage of decomposition, where topiramate loses the 
sulfamate group, preceding mass loss. In a second stage, 
sulfamate decomposes to produce sulfate anions (there is 
no detectable mass loss here) and the previous molecule 
(2,3:4,5-bis-O-methylethylidene-β-D-fructopyranose) 
decomposes to fructose, thus accounting for the 46.8% 
mass loss. Thirdly, due to the presence of sulfate ions, we 
suggest that sulfuric acid is formed and then dehydrates 
the fructose molecule, accounting for the large volume of 
the black residue observed at the end of the run. This is 
proposed in analogy to the dehydration reaction of sugars 
by sulfuric acid, which is well known to release a large 
amount of heat and water steam, expanding the charcoal 
thus formed.
Conclusions
In this letter we have presented vibrational and thermal 
properties of topiramate, an anticonvulsant drug. From this 
study, through FT-Raman, FT-IR investigations and DFT 
calculations, most of observed bands of crystalline topiramate 
were tentatively assigned. The second main point addressed 
was the thermal behavior of the material, an important issue 
for differentiating crystalline modifications, in particular 
related to materials used as medicines. The sharpness of 
DTA peaks from the topiramate crystals investigated in this 
work was a good indication of sample purity. Topiramate 
thermal stability was verified and no phase transition other 
than melting was observed. Also, an insight about the 
decomposition process was provided in this work.
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